CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÀüÈ«Àç
  • ¾Ï¼¾ÅÍÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : °£¾Ï/Ãé´ãµµ¾Ï
  • Á÷ À§: ºÎ±³¼ö(¾Ï¼¾ÅÍÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
113 (±¹³»)SCIE Current status of the korean venous thromboembolism registry.
112 (±¹¿Ü)SCI Association Between VEGF Polymorphisms and Homocysteine Levels in Patients With Ischemic Stroke and Silent Brain Infarction
111 (±¹¿Ü)SCI Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery.
110 (±¹³»)KCI Ư¹ßÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ýº´ ȯÀÚ¿¡¼­ ¹ß»ýµÈ À§Á¡¸· ÃâÇ÷ 1¿¹
109 (±¹¿Ü)SCIE Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience
108 (±¹¿Ü)SCI Association of the vascular endothelial growth factor (VEGF -1154G-A) polymorphism in patients with colorectal cancer
107 (±¹¿Ü)SCI Polymorphisms in genes involved in folate metabolism and plasma DNA methylation in colorectal cancer patients
106 (±¹¿Ü)SCI Incidence of venous thromboembolism in Korea: from Health Insurance Review and Assessment Service database
105 (±¹³»)±âŸ Çѱ¹ Á¤¸ÆÇ÷Àü ¿¹¹æ ±Ç°í¾È
104 (±¹³»)KCI ½ÊÀÌÁöÀåÀ¸·ÎÀÇ À¯ÀÔÀ¸·Î ÀÎÇÑ ºÎºÐ Æó»ö Áõ»óÀ» ³ªÅ¸³½ À§¿° ³¶Á¾¼º ¿ëÁ¾
ÀÌÀüÆäÀÌÁö À̵¿ 21 22 23 24 25 26 27 28 29 30 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729